Liquid chromatography–tandem mass spectrometry for the simultaneous quantitation of ceftriaxone, metronidazole and hydroxymetronidazole in plasma from seriously ill, severely malnourished children

We have developed and validated a novel, sensitive, selective and reproducible reversed-phase high-performance liquid chromatography method coupled with electrospray ionization mass spectrometry (HPLC–ESI-MS/MS) for the simultaneous quantitation of ceftriaxone (CEF), metronidazole (MET) and hydroxym...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Ongas, M, Standing, J, Ogutu, B, Waichungo, J, Berkley, J, Kipper, K
Formáid: Journal article
Foilsithe / Cruthaithe: Wellcome Trust 2017
Ábhair:
_version_ 1826268302551285760
author Ongas, M
Standing, J
Ogutu, B
Waichungo, J
Berkley, J
Kipper, K
author_facet Ongas, M
Standing, J
Ogutu, B
Waichungo, J
Berkley, J
Kipper, K
author_sort Ongas, M
collection OXFORD
description We have developed and validated a novel, sensitive, selective and reproducible reversed-phase high-performance liquid chromatography method coupled with electrospray ionization mass spectrometry (HPLC–ESI-MS/MS) for the simultaneous quantitation of ceftriaxone (CEF), metronidazole (MET) and hydroxymetronidazole (MET-OH) from only 50 μL of human plasma, and unbound CEF from 25 μL plasma ultra-filtrate to evaluate the effect of protein binding. Cefuroxime axetil (CEFU) was used as an internal standard (IS). The analytes were extracted by a protein precipitation procedure with acetonitrile and separated on a reversed-phase Polaris 5 C18-Analytical column using a mobile phase composed of acetonitrile containing 0.1% (v/v) formic acid and 10 mM aqueous ammonium formate pH 2.5, delivered at a flow-rate of 300 μL/min. Multiple reaction monitoring was performed in the positive ion mode using the transitions m/z555.1→m/z396.0 (CEF), m/z172.2→m/z 128.2 (MET), m/z188.0→m/z125.9 (MET-OH) and m/z528.1→m/z 364.0 (CEFU) to quantify the drugs. Calibration curves in spiked plasma and ultra-filtrate were linear (r ≥ 0.9948) from 0.4–300 μg/mL for CEF, 0.05–50 μg/mL for MET and 0.02 – 30 μg/mL for MET-OH. The intra- and inter- assay precisions were less than 9% and the mean extraction recoveries were 94.0% (CEF), 98.2% (MET), 99.6% (MET-OH) and 104.6% (CEF in ultra-filtrate); the recoveries for the IS were 93.8% (in plasma) and 97.6% (in ultra-filtrate). The validated method was successfully applied to a pharmacokinetic study of CEF, MET and MET-OH in hospitalized children with complicated severe acute malnutrition following an oral administration of MET and intravenous administration of CEF over the course of 72 hours.
first_indexed 2024-03-06T21:07:36Z
format Journal article
id oxford-uuid:3d020626-f73c-4113-a914-d0540861a86e
institution University of Oxford
last_indexed 2024-03-06T21:07:36Z
publishDate 2017
publisher Wellcome Trust
record_format dspace
spelling oxford-uuid:3d020626-f73c-4113-a914-d0540861a86e2022-03-26T14:17:00ZLiquid chromatography–tandem mass spectrometry for the simultaneous quantitation of ceftriaxone, metronidazole and hydroxymetronidazole in plasma from seriously ill, severely malnourished childrenJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3d020626-f73c-4113-a914-d0540861a86e*subject*Symplectic Elements at OxfordWellcome Trust2017Ongas, MStanding, JOgutu, BWaichungo, JBerkley, JKipper, KWe have developed and validated a novel, sensitive, selective and reproducible reversed-phase high-performance liquid chromatography method coupled with electrospray ionization mass spectrometry (HPLC–ESI-MS/MS) for the simultaneous quantitation of ceftriaxone (CEF), metronidazole (MET) and hydroxymetronidazole (MET-OH) from only 50 μL of human plasma, and unbound CEF from 25 μL plasma ultra-filtrate to evaluate the effect of protein binding. Cefuroxime axetil (CEFU) was used as an internal standard (IS). The analytes were extracted by a protein precipitation procedure with acetonitrile and separated on a reversed-phase Polaris 5 C18-Analytical column using a mobile phase composed of acetonitrile containing 0.1% (v/v) formic acid and 10 mM aqueous ammonium formate pH 2.5, delivered at a flow-rate of 300 μL/min. Multiple reaction monitoring was performed in the positive ion mode using the transitions m/z555.1→m/z396.0 (CEF), m/z172.2→m/z 128.2 (MET), m/z188.0→m/z125.9 (MET-OH) and m/z528.1→m/z 364.0 (CEFU) to quantify the drugs. Calibration curves in spiked plasma and ultra-filtrate were linear (r ≥ 0.9948) from 0.4–300 μg/mL for CEF, 0.05–50 μg/mL for MET and 0.02 – 30 μg/mL for MET-OH. The intra- and inter- assay precisions were less than 9% and the mean extraction recoveries were 94.0% (CEF), 98.2% (MET), 99.6% (MET-OH) and 104.6% (CEF in ultra-filtrate); the recoveries for the IS were 93.8% (in plasma) and 97.6% (in ultra-filtrate). The validated method was successfully applied to a pharmacokinetic study of CEF, MET and MET-OH in hospitalized children with complicated severe acute malnutrition following an oral administration of MET and intravenous administration of CEF over the course of 72 hours.
spellingShingle *subject*
Ongas, M
Standing, J
Ogutu, B
Waichungo, J
Berkley, J
Kipper, K
Liquid chromatography–tandem mass spectrometry for the simultaneous quantitation of ceftriaxone, metronidazole and hydroxymetronidazole in plasma from seriously ill, severely malnourished children
title Liquid chromatography–tandem mass spectrometry for the simultaneous quantitation of ceftriaxone, metronidazole and hydroxymetronidazole in plasma from seriously ill, severely malnourished children
title_full Liquid chromatography–tandem mass spectrometry for the simultaneous quantitation of ceftriaxone, metronidazole and hydroxymetronidazole in plasma from seriously ill, severely malnourished children
title_fullStr Liquid chromatography–tandem mass spectrometry for the simultaneous quantitation of ceftriaxone, metronidazole and hydroxymetronidazole in plasma from seriously ill, severely malnourished children
title_full_unstemmed Liquid chromatography–tandem mass spectrometry for the simultaneous quantitation of ceftriaxone, metronidazole and hydroxymetronidazole in plasma from seriously ill, severely malnourished children
title_short Liquid chromatography–tandem mass spectrometry for the simultaneous quantitation of ceftriaxone, metronidazole and hydroxymetronidazole in plasma from seriously ill, severely malnourished children
title_sort liquid chromatography tandem mass spectrometry for the simultaneous quantitation of ceftriaxone metronidazole and hydroxymetronidazole in plasma from seriously ill severely malnourished children
topic *subject*
work_keys_str_mv AT ongasm liquidchromatographytandemmassspectrometryforthesimultaneousquantitationofceftriaxonemetronidazoleandhydroxymetronidazoleinplasmafromseriouslyillseverelymalnourishedchildren
AT standingj liquidchromatographytandemmassspectrometryforthesimultaneousquantitationofceftriaxonemetronidazoleandhydroxymetronidazoleinplasmafromseriouslyillseverelymalnourishedchildren
AT ogutub liquidchromatographytandemmassspectrometryforthesimultaneousquantitationofceftriaxonemetronidazoleandhydroxymetronidazoleinplasmafromseriouslyillseverelymalnourishedchildren
AT waichungoj liquidchromatographytandemmassspectrometryforthesimultaneousquantitationofceftriaxonemetronidazoleandhydroxymetronidazoleinplasmafromseriouslyillseverelymalnourishedchildren
AT berkleyj liquidchromatographytandemmassspectrometryforthesimultaneousquantitationofceftriaxonemetronidazoleandhydroxymetronidazoleinplasmafromseriouslyillseverelymalnourishedchildren
AT kipperk liquidchromatographytandemmassspectrometryforthesimultaneousquantitationofceftriaxonemetronidazoleandhydroxymetronidazoleinplasmafromseriouslyillseverelymalnourishedchildren